Published in Hepatitis Weekly, March 26th, 2001
A report from The Netherlands indicates initial relapsers to standard interferon regimens regain viral response by extending treatments up to 36 months.
M. Damen et al., Academic Medical Center, performed a controlled, randomized trial of 88 patients that compared the efficacy of standard interferon treatment, lasting 24 weeks, with long-term treatment, which extended up to 156 weeks, depending upon patient response.
In the standard regimen, patients were given an induction dose of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.